• 1. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 2. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 3. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 4. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

Methyl 3'-Formyl-1,1'-biphenyl-3-carboxylate (CAS No. 386297-59-2): A Comprehensive Overview

Methyl 3'-Formyl-1,1'-biphenyl-3-carboxylate, identified by its CAS number 386297-59-2, is a specialized organic compound that has garnered significant attention in the field of chemical and pharmaceutical research. This compound, featuring a unique biphenyl core structure, exhibits intriguing chemical properties that make it a valuable intermediate in the synthesis of various biologically active molecules. The presence of both a formyl group and a carboxylate moiety in its molecular framework imparts distinct reactivity, making it a versatile building block for medicinal chemists and synthetic organic chemists alike.

The biphenyl scaffold is a well-known motif in medicinal chemistry, frequently employed in the design of drugs due to its ability to enhance binding affinity and metabolic stability. In particular, the 1,1'-biphenyl structure is often associated with compounds exhibiting potent pharmacological activity across multiple therapeutic areas. The introduction of a formyl group at the 3'-position and a carboxylate group at the 3-position further enhances the compound's utility, providing multiple sites for functionalization and derivatization. This dual functionality allows for the construction of complex molecules through various synthetic pathways, including condensation reactions, esterifications, and cross-coupling techniques.

Recent advancements in the field of drug discovery have highlighted the importance of heterocyclic compounds in developing novel therapeutics. Methyl 3'-Formyl-1,1'-biphenyl-3-carboxylate fits well within this paradigm, as its structure can be modified to produce derivatives with enhanced biological activity. For instance, studies have demonstrated that modifications at the biphenyl core can lead to compounds with improved binding to target enzymes and receptors. This has spurred interest in exploring its potential as a precursor for kinase inhibitors, anti-inflammatory agents, and other therapeutic candidates.

The formyl group in Methyl 3'-Formyl-1,1'-biphenyl-3-carboxylate is particularly noteworthy, as it serves as a reactive site for forming amide or imine bonds upon reaction with appropriate nucleophiles. This reactivity has been exploited in the synthesis of peptidomimetics and other protein-targeting molecules. Additionally, the carboxylate moiety can be esterified or amidated to introduce further variability into the molecular structure. Such modifications are crucial for optimizing pharmacokinetic properties and improving drug-like characteristics.

In terms of synthetic methodologies, Methyl 3'-Formyl-1,1'-biphenyl-3-carboxylate can be synthesized through multi-step processes involving palladium-catalyzed cross-coupling reactions, formylation reactions, and esterification protocols. The use of transition metal catalysts has enabled more efficient and selective transformations, reducing byproduct formation and improving overall yields. These advancements in synthetic chemistry have made it feasible to produce complex derivatives of this compound on a larger scale, facilitating its application in both academic research and industrial settings.

The pharmaceutical industry has shown particular interest in biphenyl derivatives due to their structural diversity and biological relevance. Methyl 3'-Formyl-1,1'-biphenyl-3-carboxylate has been explored as a key intermediate in several drug development projects aimed at addressing unmet medical needs. For example, researchers have investigated its potential as a precursor for compounds targeting neurological disorders, where biphenyl-based scaffolds have demonstrated promising activity profiles. Furthermore, its incorporation into libraries of small molecules has enabled high-throughput screening campaigns to identify novel leads with therapeutic potential.

The compound's unique structural features also make it an attractive candidate for materials science applications beyond pharmaceuticals. The biphenyl core can contribute to enhanced stability and rigidity in polymer matrices when incorporated into conjugated polymers or organic semiconductors. Additionally, the formyl and carboxylate groups provide opportunities for covalent attachment to surfaces or other functional moieties via click chemistry or other bioconjugation strategies.

Ongoing research continues to uncover new applications for Methyl 3'-Formyl-1,1'-biphenyl-3-carboxylate. Innovations in computational chemistry have allowed researchers to predict its reactivity and interactions with biological targets with greater accuracy. These computational models are being used to guide experimental efforts toward designing more effective derivatives with optimized pharmacological properties. Moreover, green chemistry principles are being increasingly applied to improve the sustainability of synthetic routes involving this compound.

The versatility of Methyl 3'-Formyl-1,1'-biphenyl-3-carboxylate as an intermediate underscores its importance in modern chemical synthesis. Its ability to serve as a precursor for diverse classes of biologically active molecules makes it an indispensable tool for medicinal chemists seeking to develop novel therapeutics. As research progresses，this compound is expected to remain at the forefront of innovation，contributing significantly to advancements across multiple scientific disciplines.

• 49742-56-5(Methyl 4'-Methylbiphenyl-4-carboxylate)
• 223126-96-3([1,1'-Biphenyl]-4-carboxylicacid, 3'-(hydroxymethyl)-, methyl ester)
• 281232-91-5(Biphenyl-3,4'-dicarboxylic Acid 3-Methyl Ester)
• 792-74-5(Dimethyl biphenyl-4,4'-dicarboxylate)
• 109963-61-3(4-(4-Methoxycarbonylphenyl)benzoic acid)
• 1751-97-9(Dimethyl biphenyl-3,3'-dicarboxylate)
• 281234-49-9(4-3-(Methoxycarbonyl)phenylbenzaldehyde)
• 21991-00-4([1,1'-Biphenyl]-3,5-dicarboxylicacid, 3,5-dimethyl ester)
• 720-75-2(Methyl 4-biphenylcarboxylate)
• 221021-36-9(3'-Formylbiphenyl-4-carboxylic Acid Methyl Ester)